Pre-publication history
Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design
BMC Nephrology 2011, 12:8 doi:10.1186/1471-2369-12-8
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 19 Jan 2011 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 24 Jan 2011 |
| Editor's comment | Editor's comment | 01 Feb 2011 | |
| Editorial acceptance | 01 Feb 2011 | ||
| Published | 10 Feb 2011 |
